These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 4433472)

  • 1. Pharmacokinetics of tolbutamide: prediction by concentration in saliva.
    Matin SB; Wan SH; Karam JH
    Clin Pharmacol Ther; 1974 Dec; 16(6):1052-8. PubMed ID: 4433472
    [No Abstract]   [Full Text] [Related]  

  • 2. [The effect of aging on pharmacokinetics and pharmacodynamics of tolbutamide].
    Ikegami H
    Nihon Ronen Igakkai Zasshi; 1985 May; 22(3):218-23. PubMed ID: 4046215
    [No Abstract]   [Full Text] [Related]  

  • 3. [The serum tolbutamide picture during oral treatment of diabetes].
    Leubner H; Saito S
    Wien Klin Wochenschr; 1970 May; 82(18):321-4. PubMed ID: 4930124
    [No Abstract]   [Full Text] [Related]  

  • 4. [On the problem of tolbutamide dosage in the oral treatment of diabetes mellitus, simultaneously on the problem of late failure].
    Bruns W; Hildmann W; Jutzi E
    Dtsch Z Verdau Stoffwechselkr; 1967 Feb; 26(4):175-80. PubMed ID: 5595283
    [No Abstract]   [Full Text] [Related]  

  • 5. Serum immunoreactive insulin level and tolbutamide concentration in the peripheral blood after a single oral dose of tolbutamide in man.
    Kawanishi K; Goto A; Ishida T
    Acta Med Okayama; 1973 Dec; 27(5):177-83. PubMed ID: 4273584
    [No Abstract]   [Full Text] [Related]  

  • 6. Comparison of plasma levels of antipyrine, tolbutamide, and warfarin after oral and intravenous administration.
    Andreasen PB; Vesell ES
    Clin Pharmacol Ther; 1974 Dec; 16(6):1059-65. PubMed ID: 4611464
    [No Abstract]   [Full Text] [Related]  

  • 7. Interaction between tolbutamide and ketoconazole in healthy subjects.
    Krishnaiah YS; Satyanarayana S; Visweswaram D
    Br J Clin Pharmacol; 1994 Feb; 37(2):205-7. PubMed ID: 8186066
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Determination of oral anti-diabetic agents in human body fluids using high-performance liquid chromatography.
    Hill HM; Chamberlain J
    J Chromatogr; 1978 Feb; 149():349-58. PubMed ID: 649735
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum tolbutamide and chlorpropamide concentrations in patients with diabetes mellitus.
    Melander A; Sartor G; Wåhlin E; Scherstén B; Bitzén PO
    Br Med J; 1978 Jan; 1(6106):142-4. PubMed ID: 620227
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potentiation of hypoglycemic response to intravenous tolbutamide by clofibrate.
    Ferrari C; Frezzati S; Testori GP; Bertazzoni A
    N Engl J Med; 1976 May; 294(21):1184. PubMed ID: 1264124
    [No Abstract]   [Full Text] [Related]  

  • 11. Two mintues with diabetes.
    Whitehouse FW
    Med Times; 1980 Jan; 108(1):106. PubMed ID: 7374393
    [No Abstract]   [Full Text] [Related]  

  • 12. Immunoreactive insulin level in the pancreatic vein after the intragastric administration of a single dose of tolbutamide in dogs.
    Kawanishi K; Goto A; Ishida T
    Acta Med Okayama; 1973 Dec; 27(5):185-93. PubMed ID: 4273585
    [No Abstract]   [Full Text] [Related]  

  • 13. Gas chromatographic method for determination of tolbutamide and chlorpropamide.
    Sabih K; Sabih K
    J Pharm Sci; 1970 Jun; 59(6):782-4. PubMed ID: 5423077
    [No Abstract]   [Full Text] [Related]  

  • 14. [Results of oral Diabomet therapy of diabetes mellitus].
    Ipbüker A; Erkurt R
    Turk Tip Cemiy Mecm; 1970; 36(8):287-95. PubMed ID: 5514250
    [No Abstract]   [Full Text] [Related]  

  • 15. Controversy in diabetes mellitus.
    Jackson WP
    S Afr Med J; 1979 Jun; 55(27):1104. PubMed ID: 483092
    [No Abstract]   [Full Text] [Related]  

  • 16. Determination of tolbutamide and chlorpropamide in biological fluids.
    Matin SB; Rowland M
    J Pharm Pharmacol; 1973 Feb; 25(2):186-8. PubMed ID: 4146557
    [No Abstract]   [Full Text] [Related]  

  • 17. Effect of a single administration of tolbutamide on the occurrence of alloxan diabetes in rats.
    Katsumata K; Katsumata Y
    Horm Metab Res; 1990 Mar; 22(3):192-3. PubMed ID: 2344995
    [No Abstract]   [Full Text] [Related]  

  • 18. [Increased hazards of tablet therapy in diabetes].
    Dtsch Med Wochenschr; 1970 Jul; 95(29):1544. PubMed ID: 5427548
    [No Abstract]   [Full Text] [Related]  

  • 19. [Studies on the bio-availability of tolbutamide (author's transl)].
    Rupp W; Dibbern HW; Hajdu P; Ross G; Vander Elst E
    Dtsch Med Wochenschr; 1975 Mar; 100(13):690-5. PubMed ID: 1091434
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use and misuse of oral hypoglycemic drugs.
    Graber AL
    J Tenn Med Assoc; 1971 Jul; 64(7):584-6. PubMed ID: 5562387
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.